Medplus Health Services' Q3 FY 2025-26 Quarterly Results
- 31 Jan 2026
Result Summary
- Medplus Health Services Ltd reported a 7.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 15.9%.
- Its expenses for the quarter were up by 7.6% QoQ and 15.4% YoY.
- The net profit increased 4.1% QoQ and increased 26.0% YoY.
- The earnings per share (EPS) of Medplus Health Services Ltd stood at 4.81 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 1824.36 | 1696.80 | 1573.96 | 7.5% | 15.9% |
Total Expenses | 1751.11 | 1627.86 | 1517.36 | 7.6% | 15.4% |
Profit Before Tax | 73.25 | 68.94 | 56.60 | 6.3% | 29.4% |
Tax | 15.50 | 13.43 | 10.73 | 15.4% | 44.5% |
Profit After Tax | 57.79 | 55.50 | 45.87 | 4.1% | 26.0% |
Earnings Per Share | 4.81 | 4.62 | 3.82 | 4.1% | 25.9% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Medplus Health Services Ltd is a prominent player in the pharmacy retail sector in India. The company is known for offering a wide range of pharmaceutical products, healthcare services, and other health-related consumer goods. As a leader in the industry, Medplus Health Services Ltd has established a significant presence across multiple regions in India, providing accessibility to essential medications and health products. The company operates through an extensive network of physical stores and also caters to the digital landscape through its online platform. While there is no specific recent major development provided in the data, the company continues to focus on expanding its reach and enhancing its service offerings to cater to the growing healthcare needs of the population.
Revenue
In the third quarter of the fiscal year 2026, Medplus Health Services Ltd reported a total income of ₹1824.36 crores. This reflects a quarter-over-quarter (QoQ) increase of 7.5% from ₹1696.80 crores in the second quarter of FY26. Year-over-year (YoY), the total income increased by 15.9% from ₹1573.96 crores in Q3FY25. The upward trend in revenue over both the quarter and the year highlights the company's capacity to grow its top line, possibly driven by higher sales volume or increased market penetration. The consistent growth in total income indicates a robust performance in revenue generation during the period under review.
Profitability
The profitability metrics for Medplus Health Services Ltd in Q3FY26 demonstrate positive growth. The Profit Before Tax (PBT) for the quarter was ₹73.25 crores, which shows a 6.3% QoQ increase from ₹68.94 crores in Q2FY26 and a notable 29.4% YoY increase from ₹56.60 crores in Q3FY25. The Profit After Tax (PAT) stood at ₹57.79 crores, marking a 4.1% QoQ growth from ₹55.50 crores and a 26.0% YoY increase from ₹45.87 crores in the same quarter of the previous fiscal year. The company's earnings per share (EPS) also rose by 4.1% QoQ to ₹4.81 from ₹4.62, and 25.9% YoY from ₹3.82 in Q3FY25. These metrics indicate a solid profitability performance, with both PBT and PAT showing substantial growth over the periods examined.
Operating Metrics
Medplus Health Services Ltd's total expenses for Q3FY26 were ₹1751.11 crores, representing a 7.6% QoQ increase from ₹1627.86 crores in the previous quarter. On a YoY basis, total expenses grew by 15.4% from ₹1517.36 crores in Q3FY25. The tax expenses in Q3FY26 amounted to ₹15.50 crores, reflecting a 15.4% QoQ increase from ₹13.43 crores and a 44.5% YoY increase from ₹10.73 crores. The changes in tax expenses align with the growth in profitability metrics. The data provided does not include specific figures needed to calculate ratios such as the P/E ratio, debt-to-equity ratio, or current ratio. However, the growth in both expenses and tax indicates an expanding scale of operations and a corresponding increase in tax liabilities due to higher profitability.